Cohance Lifesciences Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	2,679	3,003	4,113	4,538	3,623
Depreciation & Amortization	774.9	546	464.6	390.22	316.89
Other Amortization	-	-	-	3.91	3.85
Loss (Gain) From Sale of Assets	1.1	0.7	0.07	-0.01	-0.34
Loss (Gain) From Sale of Investments	-400.3	-449.1	-156.87	-82.03	-33.28
Stock-Based Compensation	149.2	19.7	-	-	-
Other Operating Activities	-0.6	8.5	93.58	389.52	36.65
Change in Accounts Receivable	-1,480	128.2	1,245	-1,361	133.61
Change in Inventory	741.2	816.1	-293.93	-823.37	-262.08
Change in Accounts Payable	417	-225.2	-357.99	232.04	119.45
Change in Other Net Operating Assets	-	-	-535.05	12.55	-112.71
Operating Cash Flow	2,882	3,848	4,572	3,300	3,825
Operating Cash Flow Growth	-25.11%	-15.84%	38.54%	-13.74%	-5.99%
Capital Expenditures	-1,557	-518.8	-2,859	-751.87	-1,108
Sale of Property, Plant & Equipment	-	-	0.72	0.01	0.34
Cash Acquisitions	-7,280	-	-	-	-
Investment in Securities	6,234	-3,101	844.55	-560.72	-2,005
Other Investing Activities	50.1	-4.2	63.79	-48.8	-0.54
Investing Cash Flow	-2,553	-3,624	-1,950	-1,361	-3,114
Short-Term Debt Issued	246.4	-	-	-	123.02
Long-Term Debt Issued	-	-	-	-	8.91
Total Debt Issued	246.4	-	-	-	131.93
Short-Term Debt Repaid	-	-270.4	-26.11	-385.66	-
Long-Term Debt Repaid	-108.9	-60	-241.33	-98.58	-547.27
Total Debt Repaid	-108.9	-330.4	-267.43	-484.24	-547.27
Net Debt Issued (Repaid)	137.5	-330.4	-267.43	-484.24	-415.34
Common Dividends Paid	-	-	-2,037	-1,018	-254.57
Other Financing Activities	-104.3	-69.5	-115.56	-62.31	-86.72
Financing Cash Flow	33.2	-399.9	-2,420	-1,565	-756.62
Foreign Exchange Rate Adjustments	19.9	-	-	0	0
Miscellaneous Cash Flow Adjustments	-	-	-	-	0
Net Cash Flow	381.7	-175.7	202.39	373.82	-45.13
Free Cash Flow	1,325	3,329	1,713	2,548	2,717
Free Cash Flow Growth	-60.21%	94.35%	-32.78%	-6.21%	-10.58%
Free Cash Flow Margin	11.06%	31.66%	12.78%	19.30%	26.91%
Free Cash Flow Per Share	5.18	13.08	6.73	10.01	10.67
Cash Interest Paid	104.3	69.5	115.56	62.31	89.24
Cash Income Tax Paid	834.4	1,100	1,458	1,843	1,094
Levered Free Cash Flow	1,429	2,967	1,079	1,027	1,511
Unlevered Free Cash Flow	1,506	3,014	1,159	1,066	1,568
Change in Working Capital	-321.4	719.1	57.68	-1,940	-121.73

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.